Peter Bernardo, MSPharm’63, PhD’66

Listing Row

Friday, May 16, 2014
Friday, May 16, 2014

Peter Bernardo, MSPharm’63, PhD’66, is president and chief executive officer of Xerimis Inc., a Moorestown, N.J.-based contract packaging company. He has over 35 years of experience in the pharmaceutical industry. His current firm, Xerimis, provides customized primary and secondary clinical packaging, labeling, and distribution services for companies engaged in Phase I through Phase IV clinical trials, worldwide.

Xerimis clients include pharmaceutical and biotechnology firms, as well as contract research organizations. Prior to establishing Xerimis Inc. in 2001, he successfully developed and guided Simirex Inc. through exponential growth during its 10-year existence (1988-1998). He then sold the firm to Quintiles Transnational Inc., one of the world’s largest clinical research organizations. From 1998 to 2000, Bernardo served as Quintiles’ chief operating officer, worldwide clinical supplies.

Leading up to the launch of Simirex, he was vice-president of the Flint division of Baxter Travenol where he was involved in all aspects of product development and production. Before that, he was head of formulations development at Lederle Laboratories with responsibility for both prescription and OTC product formulation. Bernardo started his industry career at Parke-Davis and then SmithKline where he gained experience in manufacturing and clinical supply production, labeling, and packaging. Bernardo is a member of the College’s Dean’s Steering Committee, and is a member of AAPS, DIA, APhA, ISPE, Rho Chi, Phi Lambda Upsilon, and Sigma Xi.